Prime Therapeutics’ Post

n-Lorem is different than standard drug development settings. Every risk/benefit decision that n-Lorem makes is in the context of the individual patient’s symptoms, status, and needs. While we cannot promise benefit, we can promise that we will do our very best in the creation of an optimal medicine. Stream part two of “How to Think About Risk”. https://lnkd.in/ehKhivXb

Throughout the #LifeSciences industry, leaders are working to use technology to improve clinical research, expand access to clinical trials, improve patient representation, and enhance drug safety. Read Seema Verma’s article for key areas to watch in 2024. https://lnkd.in/e7WE-nSg

Here's a mystery ... who can tell me the most recent patient dropout rate for clinical trials? Every article I've seen lists 30% as the average dropout rate, but when I try to track the references back to the source, I either come up with a dead end, or I'm led to a 2010 book called "The Prevention and Treatment of Missing Data in Clinical Trials," which does not list a source for this metric. I have sent this question to Tufts Center for the Study of Drug Development. #clinicaltrials #clinicaloperations #clinicalresearch #clinicaltrialmanagement

Throughout the #LifeSciences industry, leaders are working to use technology to improve clinical research, expand access to clinical trials, improve patient representation, and enhance drug safety. Read Seema Verma’s article for key areas to watch in 2024. https://lnkd.in/eMHFki6e

Throughout the #LifeSciences industry, leaders are working to use technology to improve clinical research, expand access to clinical trials, improve patient representation, and enhance drug safety. Read Seema Verma’s article for key areas to watch in 2024. https://lnkd.in/gqM9Jntz

Throughout the #LifeSciences industry, leaders are working to use technology to improve clinical research, expand access to clinical trials, improve patient representation, and enhance drug safety. Read Seema Verma’s article for key areas to watch in 2024. https://lnkd.in/gmVdTuY3

Happy Friday Folks! Today we're launching our first video in our new #GoodClinicalExplains series 🧡 When someone says human #drugtrials, what do you picture? The silent corridors of some high-tech, top-security lab where patients in white gowns are hooked up to every medical machine imaginable, and lie in wait for their doctors to adjust their dose? I hope that’s not how you see clinical research, and to be honest, in reality it’s a little less Hollywood and a lot more boring…..well, most of the time. In this video we discuss three instances where clinical trials went wrong, including: 🐘 The "Elephant Man Trial" of Theralizumab / TGN-1412 in 20016 💚 The fatal BioTrial of an endocannabinoid-promoting drug in 2015 🤖 The Thalidomide tragedy of the 1950s and 60s Why highlight these situations? Well, despite the less than desirable outcomes of the above trials, the industry has responded in a way that has lead to the robust and safe clinical trials system we have in place today. Credits: Script: Reid Rusholme Producer: Farris Beasley Presenter: Charles Beasley https://lnkd.in/gjY7cxHX

Clinical trial sponsors are increasingly asked to do more with less – making it harder to overcome challenges and accelerate drug development. But by tailoring your FSP model with applied analytics, you can improve trial outcomes while fine-tuning feasibility, site identification and overall management. Download the fact sheet to learn more. https://bit.ly/3GROO3f #FSPAdvance #Trial Design #Planning&Managment #ClinicalTrialAnalytics

Throughout the #LifeSciences industry, leaders are working to use technology to improve clinical research, expand access to clinical trials, improve patient representation, and enhance drug safety. Read Seema Verma’s article for key areas to watch in 2024. https://lnkd.in/ecvimXUJ

Happy Friday Folks! Today we're launching our first video in our new #GoodClinicalExplains series 🧡 When someone says human #drugtrials, what do you picture? The silent corridors of some high-tech, top-security lab where patients in white gowns are hooked up to every medical machine imaginable, and lie in wait for their doctors to adjust their dose? I hope that’s not how you see clinical research, and to be honest, in reality it’s a little less Hollywood and a lot more boring…..well, most of the time. In this video we discuss three instances where clinical trials went wrong, including: 🐘 The "Elephant Man Trial" of Theralizumab / TGN-1412 in 20016 💚 The fatal BioTrial of an endocannabinoid-promoting drug in 2015 🤖 The Thalidomide tragedy of the 1950s and 60s Why highlight these situations? Well, despite the less than desirable outcomes of the above trials, the industry has responded in a way that has lead to the robust and safe clinical trials system we have in place today. Credits: Script: Reid Rusholme Producer: Farris Beasley Studio: Good Clinical https://lnkd.in/guec86EF